News : Archives

From left, Daniel Ferraresi, Eliana C. Martinez, M.D., Ph.D., Judy Schaechter, M.D., MBA, Emmalee S. Bandstra, M.D., Laurence B. Gardner, M.D., Jon Batchelor, Sandy Batchelor, Julio Frenk, M.D., M.P.H., Ph.D.

Dr. Emmalee S. Bandstra Honored with 2016 Micah Batchelor Award

Renowned for her expertise in perinatal substance abuse, Emmalee S. Bandstra, M.D., recently received the prestigious 2016 Micah Batchelor Award for Excellence in Children’s Health Research. The award was presented November 8 during a ceremony at the Batchelor Children’s Research Institute before Batchelor family members and trustees of the Batchelor Family Foundation, UM and Miller School of Medicine leadership.

Read more on the Miller School Web site »

Interdisciplinary Stem Cell Institute Wins PACT Contract from NIH

The Interdisciplinary Stem Cell Institute (ISCI) has been awarded a prestigious contract for the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities from the National Heart, Lung and Blood Institute. ISCI was selected from the country’s most qualified applicants, and will play a key role in the manufacturing of stem cells and in furthering stem cell research in the U.S.

Read more on the Miller School Web site »

ISCI Members to Host Sessions at World Stem Cell Summit 2016

Various topics will be covered at this year’s event.

Joshua M. Hare, M.D.

Stem Cells Improve Heart Function for Patients with Chronic Non-Ischemic Dilated Cardiomyopathy

Researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have discovered that allogeneic human mesenchymal stem cells are efficacious and safe when used to treat patients with chronic non-ischemic dilated cardiomyopathy, a degenerative heart condition not caused by coronary disease.

Read more on the Miller School Web site »

Camillo Ricordi, M.D.

Researchers Develop Procedure for Standardized Pancreatic Islet Cell Production at Multiple Sites

The Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine, in a collaborative study with seven other institutions around the world, has demonstrated the feasibility of large-scale production of pancreatic islet cells by multiple manufacturing sites using a standardized process. Their report was published as the cover story in the November issue of Diabetes.

Read more on the Miller School Web site »

Page 3 of 21 pages  <  1 2 3 4 5 >  Last »